Argument for Personalized Vasopressors in Septic Shock

Crit Care Med. 2020 May;48(5):e439. doi: 10.1097/CCM.0000000000004248.

Authors

Andrea R Levine¹, Jonathan H Chow, Michael T McCurdy

Affiliation

¹ Division of Pulmonary and Critical Care, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD Division of Critical Care Medicine, Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, MD Division of Pulmonary and Critical Care, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.

PMID: 32301793
DOI: 10.1097/CCM.0000000000004248

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Neoplasms* / drug therapy
Norepinephrine
Shock, Septic* / drug therapy
Vasoconstrictor Agents / therapeutic use
Vasopressins

Substances

Vasoconstrictor Agents
Vasopressins
Norepinephrine